Ishii Akira, Miyamoto Susumu, Ito Yasushi, Fujinaka Toshiyuki, Sakai Chiaki, Sakai Nobuyuki
Neurol Med Chir (Tokyo). 2014;54 Suppl 2:91-7.
Parent artery occlusion (PAO) is an alternative to surgical clipping or endovascular endosaccular coil embolization for the management of cerebral aneurysms. Most giant and fusiform aneurysms are not amenable to endosaccular coil embolization due to anatomical considerations, such as a broad-neck. However, majority of reports regarding the safety of PAO are based on case series involving a relatively small number of patients. In the present study, a total of 381 consecutive patients with unruptured cerebral aneurysms who were treated with PAO were extracted from the Japanese Registry of Neuroendovascular Therapy (JR-NET) 1 and JR-NET2 database, which are nationwide surveys conducted by the Japanese Society of Neuroendovascular Therapy. The mean age of the 381 patients was 58.1 years, and 59.3% were female. The aneurysmal location included the vertebral artery (42%) and the cavernous portion of internal carotid artery (32%). The aneurysm size and shape consisted of fusiform (45%), giant (25%), and large (22%). Symptomatic lesions were present in 59.8% of the population. Technical success was achieved in 98.4%. The 30-day morbidity and mortality rates were 3.1% and 1.0%, respectively. The most frequent procedure-related complication was ischemic stroke, which occurred in 12.9% (distal embolism, 6.0%; branch occlusion, 3.9%). The 30-day morbidity and mortality rates related to ischemic strokes were 2.1% and 0.3%, respectively. PAO for unruptured aneurysms is feasible with a high technical success rate. Peri-procedural management of ischemic stroke is the key to enhance the safety of this treatment option.
对于脑动脉瘤的治疗, parent动脉闭塞(PAO)是手术夹闭或血管内囊内线圈栓塞的一种替代方法。由于解剖学因素,如宽颈,大多数巨大和梭形动脉瘤不适合囊内线圈栓塞。然而,关于PAO安全性的大多数报告是基于涉及相对少数患者的病例系列。在本研究中,从日本神经血管内治疗登记处(JR-NET)1和JR-NET2数据库中提取了总共381例连续接受PAO治疗的未破裂脑动脉瘤患者,这两个数据库是由日本神经血管内治疗学会进行的全国性调查。381例患者的平均年龄为58.1岁,59.3%为女性。动脉瘤的位置包括椎动脉(42%)和颈内动脉海绵窦段(32%)。动脉瘤的大小和形状包括梭形(45%)、巨大(25%)和大型(22%)。59.8%的患者有症状性病变。技术成功率为98.4%。30天的发病率和死亡率分别为3.1%和1.